Targeting BRD4 with PROTAC degrader ameliorates LPS-induced acute lung injury by inhibiting M1 alveolar macrophage polarization

CONCLUSION: Our study suggested that targeting BRD4 using ARV-825 is a potential therapeutic approach for ALI.PMID:38581996 | DOI:10.1016/j.intimp.2024.111991
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research